Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Sopheon juni 2022

11 Posts
| Omlaag ↓
  1. marblesthegame 6 juni 2022 19:37
    Sopheon PLC Issue of Equity & TVR

    Sopheon PLC

    06 June 2022

    For immediate release

    SOPHEON PLC

    ("Sopheon" or the "Company")

    Issue of Equity

    Sopheon, the international provider of software and services for Enterprise Innovation Management solutions, announces that, following the exercise of options by a former employee, it has allotted 10,000 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 10 June 2022.

    The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,620,104. The Company does not hold any shares in treasury. Accordingly, the figure of 10,620,104 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
  2. Tritace 10 juni 2022 10:10
    Strong start to another year of progress
    Sopheon’s AGM Statement, issued today, provides a reflection upon a busy FY2021 and looks forward to what has already started as a year of progress in FY2022. In FY2021, Sopheon grew recognised revenues and annual recurring revenues by 15%, beating market expectations in the process. The year also saw a new CEO and a reinforcement of the management team, along with the acquisition of ROI Blueprints. FY2022 appears to have started well, with six new customer wins (all SaaS based) already, compared with 10 in all of FY2021, and with the acquisition of Solverboard, announced in May. We are leaving our forecasts unchanged and continue to be impressed by Sopheon’s expansion and SaaS transition as management grows a more substantial business with greater long-term revenue visibility.

    The SaaS transition is a short-term
    drag on profitability and the market might appear to be overly penalising
    the company for following what is the correct long-term path. We urge
    investors to look ahead to where Sopheon is now clearly heading
  3. Gartje 12 juni 2022 07:29
    Nee niet verkocht! En tja wat kan je verwachten in deze tijd. Oorlog, stijgende prijzen, en veel onzekerheid! Dus was de outlook voor mij een reden ze gewoon op de plank te laten liggen.
    Zodra er rust komt in de wereld en alles weer gaat normaliseren zal de koers weer gaan stijgen. Het sentiment is negatief.
  4. marblesthegame 12 juni 2022 09:35
    quote:

    Gartje schreef op 12 juni 2022 07:29:

    Nee niet verkocht! En tja wat kan je verwachten in deze tijd. Oorlog, stijgende prijzen, en veel onzekerheid! Dus was de outlook voor mij een reden ze gewoon op de plank te laten liggen.
    Zodra er rust komt in de wereld en alles weer gaat normaliseren zal de koers weer gaan stijgen. Het sentiment is negatief.
    Ook niets verkocht.

    Er staan 10.620.104 aandelen uit.
    7.501.217 zijn van sopheon bestuurders en grote aandeelhouders
    Blijven er ruim 3 miljoen over, waarvan de meeste in handen zijn van partijen die onder de meldingsplicht blijven.
11 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.285
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.339
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.898
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.357
Aedifica 2 829
Aegon 3.257 320.053
AFC Ajax 537 7.018
Affimed NV 2 5.752
ageas 5.843 109.777
Agfa-Gevaert 13 1.856
Ahold 3.536 73.980
Air France - KLM 1.024 34.311
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.771
Alfen 12 16.275
Allfunds Group 3 1.191
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 334
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.484 114.757
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.820 240.257
AMG 965 125.715
AMS 3 73
Amsterdam Commodities 303 6.519
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.111
Apollo Alternative Assets 1 17
Apple 5 313
Arcadis 251 8.614
Arcelor Mittal 2.023 318.600
Archos 1 1
Arcona Property Fund 1 266
arGEN-X 15 9.106
Aroundtown SA 1 176
Arrowhead Research 5 9.270
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.677
ASML 1.762 76.910
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.650
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.665

Macro & Bedrijfsagenda

  1. 29 april

    1. NL producentenvertrouwen april
    2. Philips Q1-cijfers
    3. Umicore Q1-cijfers
    4. Proximus Q1-cijfers
    5. Fra BBP eerste kwartaal (voorlopig)
    6. AkzoNobel €1,54-ex-dividend
    7. Besi €2,15 ex-dividend
    8. Fugro €0,40 ex-dividend
    9. Heineken €1,04 ex-dividend
    10. Vastned €1,28 ex-dividend
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht